According to a market report by Lucintel, the future of the 3D bioprinting market looks promising with opportunities in the pharmaceutical, biotechnology, research organizations, and academic institutes. The 3D bioprinting market is expected to grow with a CAGR of 26% from 2019 to 2024. The major growth drivers for this market are growing demand for organ transplantation, rise in public and private funding to support 3D bioprinting research activities, increasing use of 3D bioprinting in the drug discovery process, and growing focus of market players on 3D bioprinting.
Within the 3D bioprinting market tissue and organ generation, prosthetic and implants, dental, biosensors, consumer/personal product testing, and food and animal product are the major applications.
Living cells, extracellular matrices, and hydrogels are the major bio-materials of the 3D bioprinting market. This technique involves 3D printing of biological tissues and organs through layering of living cells. 3D bioprinting is mainly employed for developing organ and tissue constructs, which can be used for R&D of drugs, scaffolds, and development of medical implants.
North America will remain the largest market over the forecast period due to an increasing target population base, presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.
Organovo Holdings, Envisiontec, Nano 3D Biosciences, Cyfuse Biomedical, Regenhu, Aspect Biosystems, Biobots, Cellink, Gesim, and Poietis are among the major manufacturers of 3D bioprinting.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the 3D bioprinting market by technology, bio-material, application, end use industry, and region. Lucintel has prepared a comprehensive research report titled " 3D Bioprinting Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the 3D bioprinting market by technology, bio-material, application, end use industry, and region as follows:
By Technology [$M shipment analysis for 2013 – 2024]:
• Magnetic 3D Bioprinting
• Laser-assisted Bioprinting
• Inkjet 3D Bioprinting
• Microextrusion 3D Bioprinting
By Bio-Material Type [$M shipment analysis for 2013 – 2024]:
• Living Cells
• Extracellular Matrices
• Hydrogels
• Other Biomaterials
By Application [$M shipment analysis for 2013 – 2024]:
• Tissue and Organ Generation
• Prosthetic and Implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Food and Animal Product
• Others
By End Use Industry [$M shipment analysis for 2013 – 2024]:
• Pharmaceutical & Biotechnology
• Research Organizations & Academic Institutes
• Others
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Spain
o Italy
• Asia-Pacific
o China
o India
o Japan
• Rest of the World
o Brazil
This report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers following 11 key questions:

Q.1 What are some of the most promising potential, high-growth opportunities for the 3D bioprinting market by technology (magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, and microextrusion 3D bioprinting), bio-material (living cells, extracellular matrices, and hydrogels), application (tissue and organ generation, prosthetic and implants, dental, biosensors, consumer/personal product testing, and food and animal product, and others), end use industry (pharmaceutical & biotechnology and research organizations & academic institutes), and region (North America, Europe, Asia-Pacific and Rest of the World)
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the 3D bioprinting market?
Q.5 What are the business risks and threats to the 3D bioprinting market?
Q.6 What are emerging trends in this 3D bioprinting market and the reasons behind them?
Q.7 What are some changing demands of customers in the 3D bioprinting market?
Q.8 What are the new developments in the 3D bioprinting market? Which companies are leading these developments?
Q.9 Who are the major players in this 3D bioprinting market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this 3D bioprinting area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities have taken place in the last 5 years in this, 3D bioprinting market?